140 related articles for article (PubMed ID: 9710043)
1. Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy.
Mirabella M; Galluzzi G; Manfredi G; Bertini E; Ricci E; De Leo R; Tonali P; Servidei S
Neurology; 1998 Aug; 51(2):592-5. PubMed ID: 9710043
[TBL] [Abstract][Full Text] [Related]
2. Analysis of dystrophin gene deletions in patients from the Mexican population with Duchenne/Becker muscular dystrophy.
Coral-Vázquez R; Arenas D; Cisneros B; Peñaloza L; Kofman S; Salamanca F; Montañez C
Arch Med Res; 1993; 24(1):1-6. PubMed ID: 8292871
[TBL] [Abstract][Full Text] [Related]
3. [Deletion analysis of the dystrophin gene in patients with Duchenne's muscular dystrophy in Tajikistan].
Odinokova ON; Puzyrev VP; Radzhabaliev ShF; Rakhmonov RA
Genetika; 1996 Oct; 32(10):1392-5. PubMed ID: 9091412
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of deletions in the dystrophin gene in patients with Duchenne muscular dystrophy in the Bashkir Republic].
Grinchuk OV; Khidiiatova IM; Kiselev AV; Magzhanov RV; Khusnutdinova EK
Genetika; 1999 Apr; 35(4):551-5. PubMed ID: 10420280
[TBL] [Abstract][Full Text] [Related]
5. Dystrophin expression in Duchenne patients with "in-frame" gene deletions.
Nicholson LV; Bushby KM; Johnson MA; Gardner-Medwin D; Ginjaar IB
Neuropediatrics; 1993 Apr; 24(2):93-7. PubMed ID: 8327067
[TBL] [Abstract][Full Text] [Related]
6. Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctions.
Beggs AH; Hoffman EP; Kunkel LM
Am J Med Genet; 1992 Oct; 44(3):378-81. PubMed ID: 1488990
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal deletion of 53% of dystrophin results in an intermediate Duchenne-Becker muscular dystrophy phenotype.
Takeshima Y; Nishio H; Narita N; Wada H; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
Neurology; 1994 Sep; 44(9):1648-51. PubMed ID: 7936290
[TBL] [Abstract][Full Text] [Related]
8. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
[TBL] [Abstract][Full Text] [Related]
9. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
Shomrat R; Gluck E; Legum C; Shiloh Y
Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
[TBL] [Abstract][Full Text] [Related]
10. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
[TBL] [Abstract][Full Text] [Related]
11. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
[TBL] [Abstract][Full Text] [Related]
12. A Japanese boy with myalgia and cramps has a novel in-frame deletion of the dystrophin gene.
Ishigaki C; Patria SY; Nishio H; Yabe M; Matsuo M
Neurology; 1996 May; 46(5):1347-50. PubMed ID: 8628480
[TBL] [Abstract][Full Text] [Related]
13. Screening Duchenne and Becker muscular dystrophy patients for deletions in 30 exons of the dystrophin gene by three-multiplex PCR.
Covone AE; Caroli F; Romeo G
Am J Hum Genet; 1992 Sep; 51(3):675-7. PubMed ID: 1496997
[No Abstract] [Full Text] [Related]
14. Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates.
Comi GP; Prelle A; Bresolin N; Moggio M; Bardoni A; Gallanti A; Vita G; Toscano A; Ferro MT; Bordoni A
Brain; 1994 Feb; 117 ( Pt 1)():1-14. PubMed ID: 8149204
[TBL] [Abstract][Full Text] [Related]
15. Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size?
Fanin M; Freda MP; Vitiello L; Danieli GA; Pegoraro E; Angelini C
Muscle Nerve; 1996 Sep; 19(9):1154-60. PubMed ID: 8761273
[TBL] [Abstract][Full Text] [Related]
16. [Family study allows more optimistic prognosis and genetic counselling in a child with a deletion of exons 50-51 of the dystrophin gene].
Lesca G; Testard H; Streichenberger N; Pelissier JF; Lestra C; Burel E; Jonveaux P; Michel-Calemard L
Arch Pediatr; 2007 Mar; 14(3):262-5. PubMed ID: 17258443
[TBL] [Abstract][Full Text] [Related]
17. Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its potential use for gene therapy.
Passos-Bueno MR; Vainzof M; Marie SK; Zatz M
Hum Mol Genet; 1994 Jun; 3(6):919-22. PubMed ID: 7951237
[TBL] [Abstract][Full Text] [Related]
18. More deletions in the 5' region than in the central region of the dystrophin gene were identified among Filipino Duchenne and Becker muscular dystrophy patients.
Cutiongco EM; Padilla CD; Takenaka K; Yamasaki Y; Matsuo M; Nishio H
Am J Med Genet; 1995 Nov; 59(2):266-7. PubMed ID: 8588598
[No Abstract] [Full Text] [Related]
19. [Molecular pathology of Duchenne and Becker muscular dystrophy].
Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC
C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222
[TBL] [Abstract][Full Text] [Related]
20. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
